This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Platelet & Coagulation disorders, Subject name: Medicine
[{'content': 'Which of the following is given to treat thrombocytopenia secondary to anti-cancer therapy and is known to stimulate progenitor megakaryocytes? \nSelect and explain. \nA. Filgrastim, B. Oprelvekin, C. Erythropoietin, D. Anagrelide', 'role': 'user'}, {'content': 'Answer: B \nExplanation: Oprelvekin or recombinant interleukin-11- used in management of chemotherapy-induced thrombocytopenia S/E- fluid retention, hea failure, and arrhythmias. Two drugs that activate the thrombopoietin receptor: Romiplostim Eltrombopag These are used in idiopathic thrombocytopenia.', 'role': 'assistant'}]